术后随访6个月，所有患者均无脑缺血事件发生。
No cerebral ischemic event occurred in all patients during the 6-month follow-up.
观察CS术后1个月复发缺血事件与氯吡格雷抵抗的关系。
To investigate the relationship between the recurrence of ischemic events and clopidogrel resistance in 1 month after CS.
冠状动脉疾病或脑血管疾病患者出血可引起缺血事件的发生。
In patients with coronary artery disease or cerebrovascular disease, bleeding is related to the subsequent occurrence of ischemic events.
结果显示，缺血事件中没有差异，但是使用磺达肝癸钠出血较少。
There was no difference in ischemic events but less bleeding with fondaparinux.
外周血管疾病患者发生缺血事件的高风险，因此应用抗栓药物治疗。
Patients with peripheral arterial disease are at high risk of ischemic events and therefore are treated with antithrombotics.
然而，在缺血事件发生后，有症状的斑块重塑的自然过程却很少被研究。
However, the natural course of symptomatic plaque remodeling after ischemic events is relatively unexplored.
当抗凝治疗预防新发缺血事件失败，依靠支架辅助血管成形术的颈内动脉再通最近被提倡。
Recanalization of internal carotid artery dissection by stent-assisted angioplasty has recently been proposed when anticoagulation fails to prevent a new ischemic event.
他总结道，复合结果在数字上是支持比伐卢定，因为(它)不增加缺血事件却降低严重出血的发生。
He concluded that the composite results were numerically in favor of bivalirudin, with no increase in ischemic events but a marked reduction in major bleeding.
在FDA的罗格列酮听证会上，数个荟萃分析表明使用该药的患者其心肌缺血事件的风险显著增大。
In the FDA hearing on rosiglitazone, several meta-analyses revealed a significant increase in the risk of myocardial ischemic events among patients taking rosiglitazone.
反应蛋白(CRP)作为一种全身性炎症反应的标记物，被认为可预测未来冠脉缺血事件的发生。
C-reactive protein (CRP), a systemic marker for inflammation, have been found to predict future coronary events.
临床上很少对偏头痛性梗死进行诊断，因为在大多数卒中患者中，发现的是引起缺血事件的其他原因。
A diagnosis of migrainous infarction is seldom made because, in most stroke patients, other causes for the ischemic event are discovered.
目的观察在原发高脂血症合并急性冠脉综合征早期应用辛伐他汀对降低血脂的疗效及缺血事件发生的影响。
Objective Observe the blood lipid-reducing efficacy of the simvastatin on earlier stage of primary hyperlipaemia and acute coronary syndrome and the affection of ischemia event.
在急性心脏缺血事件中J波单独出现，或与ST段抬高，或与T波电交替同时出现时均是心脏猝死的高危预警指标。
When present alone, or together with elevated ST segment or t wave, patients were at high risk of cardial sudden death.
目的观察血管紧张素转换酶抑制剂(acei)减少急性心肌梗塞(ami)后患者心肌缺血及其相关事件的影响。
AIM to study the effect of angiotensin converting inhibitor (ACEI) reduces myocardial ischemia and related events after acute myocardial infarction (AMI).
心肌缺血主要是一种代谢性事件。
对所有患者进行随访，观察心血管死亡、心肌梗死、需要住院治疗的不稳定型心绞痛、卒中或短暂性脑缺血的混合事件发生情况。
All patients were followed for the composite outcome of cardiovascular death, mi, unstable angina requiring hospitalization, stroke, or transient ischemic attack.
通过对罗格列酮心脏缺血性事件的描述和分析，探讨美国药品监管模式中存在的问题，为我国药品安全监管工作提供借鉴。
Through the description and analysis on case of rosiglitazone ischemic events, the article discusses the problem existing in US regulatory mode to provide reference for Chinas drug administration.
主要的衡量结果为动脉粥样硬化性事件，包括致命的或非致命性缺血性心脏病，致命性的或非致命性中风及外周动脉疾病。
The main outcome measures were atherosclerotic events, including fatal or nonfatal ischemic heart disease, fatal or nonfatal stroke, and peripheral arterial disease.
可 以检测的心脏事件可以是退行性心肌病、急性心肌梗死、心律失常、心肌缺血、或心室功能受损。
The cardiac event that may be detected may be degenerative cardiomyopathy, acute myocardial infarction, arrhythmia, myocardial ischaemia, or compromised ventricular function.
结论：在既往有卒中或短暂脑缺血发作病史的门诊患者中，ESRS对卒中复发或大血管事件进行精确的风险分层。
Conclusions - In out patients with previous stroke or transient ischemic attack, the ESRS accurately stratified the risk of recurrent stroke or major vascular events.
目的：探讨动态心电图对老年冠心病、心肌缺血的检出率，预防严重心脏事件发生的意义。
Objective: Improve the examine rate of dynamic electrocardiogram toward coronary heart disease, myocardial ischemia of the olds and to prevent serious cardiac accident.
此外，还发现，一年内包括缺血性事件和严重出血患者的危险因素和死亡无关。
In addition to patient risk factors, ischemic events and major bleeding were found to be independent predictors of death at 1 year.
随访中的累计死亡率是8.1%，死亡或非致死性心肌缺血等相反终止事件的发生率是13.7%。
The cumulative mortality rate during follow-up was 8.1%, and the incidence of the composite end point of death or nonfatal (re -) MI was 13.7%.
大量研究已显示，抗血小板药物能得到减少DM缺血性事件的临床获益。
Numerous studies have shown the clinical benefit of antiplatelet agents in reducing ischemic events in DM patients.
然而，尽管抗血小板药物达到了临床获益，但DM出现缺血性事件的风险仍大于非dm的风险。
However, despite the clinical benefit achieved with antiplatelet agents, patients with DM continue to have an increased risk of ischemic events compared to non-DM.
因此，血小板反应性持续增加而引起这些受试者暴露缺血性事件风险增加。
Thus, persistence of enhanced platelet reactivity exposes these subjects to an increased ischemic risk.
在缺血性胸痛的患者以及已知或怀疑处于稳定期的冠心病患者当中，我们和其他人的研究已经证明负荷CMR在预测心脏病事件中效用。
In patients with ischemic chest pain and known or suspected coronary artery disease in a stable phase, we and others have recently demonstrated the usefulness of stress CMR to predict cardiac events.
在缺血性胸痛的患者以及已知或怀疑处于稳定期的冠心病患者当中，我们和其他人的研究已经证明负荷CMR在预测心脏病事件中效用。
In patients with ischemic chest pain and known or suspected coronary artery disease in a stable phase, we and others have recently demonstrated the usefulness of stress CMR to predict cardiac events.
应用推荐